(Q38095771)

English

Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction

scientific article published on May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 August 2017

Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction (English)

1 reference

Europe PubMed Central

28 August 2017

Cytomegalovirus

0 references

Miguel López-Botet

4

object named as

Miguel López-Botet

0 references

1

object named as

Aura Muntasell

1 reference

Europe PubMed Central

28 August 2017

object named as

Ana Angulo

3

0 references

object named as

Carlos Vilches

2

0 references

language of work or name

0 references

publication date

1 May 2013

1 reference

Europe PubMed Central

28 August 2017

European Journal of Immunology

1 reference

Europe PubMed Central

28 August 2017

43

1 reference

Europe PubMed Central

28 August 2017

5

1 reference

Europe PubMed Central

28 August 2017

1133-1141

1 reference

Europe PubMed Central

28 August 2017

NK cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Unifying concepts of MHC-dependent natural killer cell education

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Infection in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Role of CMV in immune senescence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Modulation of natural killer cells by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Natural killer cell activation and inhibition by receptors for MHC class I.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Association of DAP12 with activating CD94/NKG2C NK cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

CD94 is essential for NK cell-mediated resistance to a lethal viral disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Reprogramming of CTLs into natural killer-like cells in celiac disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The impact of differential antiviral immunity in children and adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Molecular genetic analyses of human NKG2C (KLRC2) gene deletion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NKG2C deletion is a risk factor of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Human NK cells can control CMV infection in the absence of T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Vital involvement of a natural killer cell activation receptor in resistance to viral infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Recognition of a virus-encoded ligand by a natural killer cell activation receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Adaptive immune features of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Innate or adaptive immunity? The example of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NK cells and immune "memory"

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Herpesvirus latency confers symbiotic protection from bacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Immune modulation during latent herpesvirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Association of Atherosclerosis With Expression of the LILRB1 Receptor By Human NK and T-Cells Supports the Infectious Burden Hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

CD56 negative NK cells: origin, function, and role in chronic viral disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

The Contribution of Cytomegalovirus to Changes in NK Cell Receptor Expression in HIV‐1–Infected Individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

21 January 2018

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural killer cells act as rheostats modulating antiviral T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201243117

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201243117

1 reference

Europe PubMed Central

28 August 2017

1 reference

Europe PubMed Central

28 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38095771&oldid=1741101463"